(Part 25) Ultrasound Blood–Brain Barrier Opening and Aducanumab in Alzheimer’s Disease

(Part 24) A randomized trial of deep-brain stimulation for Parkinson's disease

(Part 23) Targeted Temperature Management – HYPERION Trial

(Part 22) Liberal or Restrictive Transfusion Strategy in Aneurysmal Subarachnoid Hemorrhage

(Part 21) Antiplatelet treatment compared with anticoagulation treatment for CADISS

(Part 20) Lecanemab in Early Alzheimer’s Disease

(Part 19) Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage

(Part 18) Time is Brain—Quantified

(Part 17) Safety and efficacy of fluoxetine on functional outcome after acute stroke

(Part 16) - The INTERACT3 Trial

(Part 15) Long term efficacy and safety of thalamic stimulation for drug resistant partial epilepsy

(Part 14) - Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus

(Part 13) - Randomized controlled trial of deutetrabenazine for tardive dyskinesia

(Part 12) Dexamethasone in Adults with Bacterial Meningitis

(Part 11) A Randomized, Controlled Trial of Surgery for Temporal Lobe Epilepsy

(Part 10) - A Randomized Trial of Deep Brain Stimulation for Parkinson’s Disease

(Part 9) - The LIBERTY Trial

(Part 8) - Tissue Plasminogen Activator for Acute Ischemic Stroke

(Part 7) - ECASS and NIND trials

(Part 5) - Standard and New Antiepileptic Drugs (SANAD) Trial – Arm B

(Part 4) - Standard and New Antiepileptic Drugs (SANAD) Trial – Arm A

(Part 3) Landmark Trials in Neurology, Part 3 The MR CLEAN Trial 2015 and the DAWN Trial 2018

(Part 2) Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack

(Part 1) Landmark Neurology Trial Part 1 Optic Neuritis Treatment Trial

Why We Use Now You Know Neuro – Resident Testimonials (Part 1)

Why We Use Now You Know Neuro – Resident Testimonials (Part 2)